This topic contains a solution. Click here to go to the answer

Author Question: The judgment debtor is: A. The winner at trial owed damages from the opposing party B. The loser ... (Read 97 times)

olgavictoria

  • Hero Member
  • *****
  • Posts: 528
The judgment debtor is:
 
  A. The winner at trial owed damages from the opposing party
  B. The loser at trial that owes damages to the opposing party
  C. The winner at trial but not owed any money award
  D. The loser at trial but not owed any money award
  E. None of the above

Question 2

Bankruptcy can limit efforts to collect on a judgment, but the filing of a bankruptcy petition does not mean the judgment creditor will not be paid.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meganlapinski

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

B

Answer to Question 2

True





 

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library